Moderna collaborates with Thermo Fischer Scientific to ramp up its COVID – 19 vaccine production Moderna Inc had entered into an agreement with Thermo Fischer Scientific on 1 June 2021. Moderna did this collaboration to scale up the manufacturing and packaging of Moderna’s COVID – 19 vaccine. Moderna collaborates with Thermo Fischer Scientific: Per this […]
Moderna collaborates with Thermo Fischer Scientific Read More »
On 2 June 2021, the antibody-drug combination by the US drugmaker Eli Lilly was granted EUA[1] in India. This combination was permitted for the treatment of mild to moderate COVID -19 in India. The monoclonal antibody drugs, bamlanivimab 700 mg, and etesevimab 1400 mg, have received permission for restricted use. Eli Lilly has stated that
JB Chemicals & Pharma launches NOSMOK nicotine lozenges to help with smoking cessation : On 31 May 2021, JB Chemicals and Pharmaceuticals launched medicated nicotine lozenges. An artificial intelligence-enabled chatbot called ‘Dr. Will’ was also launched alongside this product. [1] The drug makers used the occasion of the “World No Tobacco Day” for the launch.
Dr. Reddy’s to charge Rs. 990 for each sachet of the anti-COVID-19 medicine by DRDO (2-DG) Dr. Reddy’s has recently fixed the price of DRDO’s[1] 2-DG (2-deoxy-D-glucose) at Rs. 990 per sachet. It was revealed that this would be provided in the central and state government hospitals at a discounted price. 2-DG is an anti-COVID-19
GSK and Vir Biotechnology plan to launch Sotrovimab for treating COVID-19 in India : GlaxoSmithKline (GSK), together with the US-based Vir Biotechnology, is planning to launch a single-dose mAb[1] in India. This drug is called Sotrovimab (VIR-7831) and has received the EUA[2] from the USFDA[3]. It was approved for treating mild to moderate COVID-19 in high-risk
GSK and Vir Biotechnology plan to launch Sotrovimab Read More »
USFDA approves Gland Pharma’s generic Foscarnet Sodium Injection, single – dose bag for infusion : Gland Pharma had sought out the USFDA’s[1] approval for one of its generic products. This product is called Foscarnet Sodium injection, 6000 mg/ 250 mL ( 24 mg/ mL ) Single-Dose Bag for Infusion. On 22 April 2021, the company
US pharma firms Gilead and Mylan deliver 50,000 vials of Amphotericin B to India : India received around 50,000 vials of Amphotericin-B from US-based Gilead Sciences and Mylan on 28 May 2021. This drug is used for treating patients with black fungus. The Union Minister of State for Chemicals and Fertilizers has expressed his gratitude
pharma News June 2021: Read what is happening in India and around the globe in the pharma industry. AstraZeneca’s India vaccine partner seeking EU travel resolution: 28 June 2021 European Union’s vaccine passport program has allowed only people vaccinated with one of the four Western-made vaccines to travel within the bloc from 1 July 2021.
Zydus seeks DCGI’s approval for conducting clinical trials of its COVID-19 biological therapy : Zydus Cadila has recently sought the DCGI’s[1] approval for conducting clinical trials of its new COVID-19 treatment. This is a monoclonal antibody (mAb) based cocktail that can neutralize COVID-19 infection. 1 The pharma firm stated that the antibodies are made by cloning
Zydus seeks DCGI’s approval for COVID-19 biological therapy Read More »
Zydus and TLC sign a pact to commercialize AmphoTLC in India Zydus Cadila and Taiwan-based pharma firm TLC have signed a pact to market Liposomal Amphotericin B (AmphoTLC) in India. This news was disclosed on 26 May 2021. 1 The companies have decided to commercialize AmphoTLC (Amphotericin B Liposome for Injection 500 mg) in India.
Zydus and TLC to commercialize AmphoTLC in India Read More »
